DE69819203D1 - Trinkbares arzneimittel - Google Patents

Trinkbares arzneimittel

Info

Publication number
DE69819203D1
DE69819203D1 DE69819203T DE69819203T DE69819203D1 DE 69819203 D1 DE69819203 D1 DE 69819203D1 DE 69819203 T DE69819203 T DE 69819203T DE 69819203 T DE69819203 T DE 69819203T DE 69819203 D1 DE69819203 D1 DE 69819203D1
Authority
DE
Germany
Prior art keywords
medicinal product
drinking medicinal
drinking
product
medicinal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69819203T
Other languages
English (en)
Other versions
DE69819203T2 (de
Inventor
Claude Aleman
Philippe Bastard
Marielle Bonnel
Thierry Breul
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Sanofi Synthelabo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo SA filed Critical Sanofi Synthelabo SA
Publication of DE69819203D1 publication Critical patent/DE69819203D1/de
Application granted granted Critical
Publication of DE69819203T2 publication Critical patent/DE69819203T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40Cyclodextrins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10Laxatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Nanotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Diabetes (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
DE69819203T 1997-12-24 1998-12-14 Trinkbares arzneimittel Expired - Fee Related DE69819203T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9716529 1997-12-24
FR9716529A FR2772614B1 (fr) 1997-12-24 1997-12-24 Solution aqueuse a base de chlorhydrate de 1- [ 2-(2-naphtyl)ethyl]-4- (3-trifluoromethylphenyl) -1,2,3,6-tetrahydropyridine et composition pharmaceutique buvable en contenant
PCT/FR1998/002712 WO1999033466A1 (fr) 1997-12-24 1998-12-14 Composition pharmaceutique buvable

Publications (2)

Publication Number Publication Date
DE69819203D1 true DE69819203D1 (de) 2003-11-27
DE69819203T2 DE69819203T2 (de) 2004-07-15

Family

ID=9515152

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69819203T Expired - Fee Related DE69819203T2 (de) 1997-12-24 1998-12-14 Trinkbares arzneimittel

Country Status (25)

Country Link
US (1) US6191137B1 (de)
EP (1) EP1041984B1 (de)
JP (1) JP2002510599A (de)
AR (1) AR017722A1 (de)
AT (1) ATE252384T1 (de)
AU (1) AU1880599A (de)
BR (1) BR9814414A (de)
CA (1) CA2315696C (de)
CO (1) CO4970813A1 (de)
DE (1) DE69819203T2 (de)
DK (1) DK1041984T3 (de)
DZ (1) DZ2676A1 (de)
ES (1) ES2209238T3 (de)
FR (1) FR2772614B1 (de)
GT (1) GT199800204A (de)
HU (1) HUP0101012A3 (de)
MY (1) MY117156A (de)
NO (1) NO20003284L (de)
PT (1) PT1041984E (de)
SA (2) SA99191003B1 (de)
SI (1) SI1041984T1 (de)
TW (1) TW536409B (de)
UY (1) UY25320A1 (de)
WO (1) WO1999033466A1 (de)
ZA (1) ZA9811824B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004087870A2 (en) * 2003-03-25 2004-10-14 The Johns Hopkins University Neuronal cell lineages and methods of production thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2702656B1 (fr) * 1993-03-18 1995-06-16 Sanofi Elf Utilisation de derives de la tetrahydropyridine pour la preparation de medicaments cardioprotecteurs.

Also Published As

Publication number Publication date
HUP0101012A2 (hu) 2001-08-28
ATE252384T1 (de) 2003-11-15
CO4970813A1 (es) 2000-11-07
DZ2676A1 (fr) 2004-09-19
SA99191002B1 (ar) 2006-03-07
NO20003284L (no) 2000-08-24
SA99191003B1 (ar) 2006-10-02
UY25320A1 (es) 2000-10-31
DE69819203T2 (de) 2004-07-15
JP2002510599A (ja) 2002-04-09
FR2772614B1 (fr) 2000-03-10
GT199800204A (es) 2000-06-14
WO1999033466A1 (fr) 1999-07-08
US6191137B1 (en) 2001-02-20
AR017722A1 (es) 2001-09-12
NO20003284D0 (no) 2000-06-22
AU1880599A (en) 1999-07-19
DK1041984T3 (da) 2004-02-16
EP1041984B1 (de) 2003-10-22
BR9814414A (pt) 2000-10-10
MY117156A (en) 2004-05-31
FR2772614A1 (fr) 1999-06-25
ZA9811824B (en) 1999-06-29
TW536409B (en) 2003-06-11
ES2209238T3 (es) 2004-06-16
CA2315696A1 (en) 1999-07-08
CA2315696C (en) 2008-01-29
SI1041984T1 (en) 2004-04-30
HUP0101012A3 (en) 2002-12-28
PT1041984E (pt) 2004-02-27
EP1041984A1 (de) 2000-10-11

Similar Documents

Publication Publication Date Title
ATE248594T1 (de) Irbesartanhaltiges arzneimittel
DE69908021D1 (de) Ziprasidonhaltige Arzneimittel
DE69900162D1 (de) Arzneimittel enthaltend Oxaliplatin
ATE187063T1 (de) Arzneimittel
DE122010000011I1 (de) Flüssige gonadotropinhaltige Arzneimittel
ATE367150T1 (de) Arzneimittel
FI954402A (fi) Uusi farmaseuttinen tuote
PT862863E (pt) Produto cerealifero contendo probioticos
DE60004685D1 (de) Pyrazolopyrimidine als arzneimittel
FI970038A0 (fi) Kosteuttava valmiste
DE69840622D1 (de) Kosmetikprodukt
DE19581419T1 (de) Würzmittel-Abgabevorrichtung
ATE237320T1 (de) Venlafaxinhaltiges arzneimittel mit verlängerter wirkstoffabgabe
GB9801538D0 (en) Pharmaceutical product
DE69709349D1 (de) Arzneimittel bestehend aus diclofenac
ATE269337T1 (de) Trizyclische delta3-pyridine als arzneimittel
BR9711981A (pt) Produto farmac-utico cristalino
EA199900672A1 (ru) Гомеопатическое лекарственное средство
FI951155A0 (fi) Farmaseuttinen valmiste
DE60008237D1 (de) Lamivudin enthaltende arzneimittel
DE69819203D1 (de) Trinkbares arzneimittel
DE59805373D1 (de) Nephroprotektive Arzneimittel
EA199900673A1 (ru) Гомеопатическое лекарственное средство
KR960010468A (ko) 위생제품 포장체
FI962036A (fi) Lääkesäiliö

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: SANOFI-AVENTIS, PARIS, FR

8339 Ceased/non-payment of the annual fee